Top of page

Europe

Region

Filters

CureVac $245.3 million IPO

Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which…

Linde $1 billion notes offering

Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes…
Back to top